Lixte Historical Valuation

LIXT Stock  USD 1.27  0.02  1.60%   
Some fundamental drivers such as market cap or Lixte Biotechnology enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Lixte Biotechnology valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Lixte Biotechnology's future value.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lixte Biotechnology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

About Lixte Valuation Data Analysis

Valuation is the financial process of determining what Lixte Biotechnology is worth. Lixte Biotechnology valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Lixte Biotechnology valuation ratios help investors to determine whether Lixte Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lixte with respect to the benefits of owning Lixte Biotechnology security.

Lixte Biotechnology Valuation Data Chart

Market Cap is likely to drop to about 5 M in 2025. Enterprise Value is likely to drop to about 3.9 M in 2025

Enterprise Value

Enterprise Value (or EV) is usually referred to as Lixte Biotechnology theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Lixte Biotechnology debt, but would also pocket its cash. Enterprise Value is more accurate representation of Lixte Biotechnology value than its market capitalization because it takes into account all of Lixte Biotechnology Holdings existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Lixte Stock Analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.